Chauvenet AR - Search Results

1

Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer.

Goorin AM, Chauvenet AR, Perez-Atayde AR, Cruz J, McKone R, Lipshultz SE. Goorin AM, et al. Among authors: chauvenet ar. J Pediatr. 1990 Jan;116(1):144-7. doi: 10.1016/s0022-3476(05)81668-3. J Pediatr. 1990. PMID: 2295956 No abstract available.

2

Combination high-dose etoposide and vincristine infusion.

Jackson DV Jr, Cruz JM, White DR, Muss HB, Chauvenet AR. Jackson DV Jr, et al. Among authors: chauvenet ar. Invest New Drugs. 1990;8 Suppl 1:S59-64. doi: 10.1007/BF00171985. Invest New Drugs. 1990. PMID: 2380018

3

Optimizing care with rasburicase.

Cruz JM, Chauvenet AR. Cruz JM, et al. Among authors: chauvenet ar. J Support Oncol. 2005 Mar-Apr;3(2):127-8. J Support Oncol. 2005. PMID: 15796444 No abstract available.

4

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

Schwartz CL, Constine LS, Villaluna D, London WB, Hutchison RE, Sposto R, Lipshultz SE, Turner CS, deAlarcon PA, Chauvenet A. Schwartz CL, et al. Blood. 2009 Sep 3;114(10):2051-9. doi: 10.1182/blood-2008-10-184143. Epub 2009 Jul 7. Blood. 2009. PMID: 19584400 Free PMC article. Clinical Trial.

5

Cures in childhood cancer.

Chauvenet AR, Wofford MM. Chauvenet AR, et al. Pediatr Rev. 1990 Apr;11(10):311-7. doi: 10.1542/pir.11-10-311. Pediatr Rev. 1990. PMID: 2195476 Review. No abstract available.

6

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.

Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, de Alarcón PA, Schwartz C, Chauvenet A. Tebbi CK, et al. Pediatr Blood Cancer. 2012 Dec 15;59(7):1259-65. doi: 10.1002/pbc.24279. Epub 2012 Aug 21. Pediatr Blood Cancer. 2012. PMID: 22911615 Free PMC article. Clinical Trial.

7

Phase II trial of vincristine infusion in acute leukemia.

Jackson DV Jr, Chauvenet AR, Callahan RD, Atkins JN, Trahey TF, Spurr CL. Jackson DV Jr, et al. Among authors: chauvenet ar. Cancer Chemother Pharmacol. 1985;14(1):26-9. doi: 10.1007/BF00552720. Cancer Chemother Pharmacol. 1985. PMID: 3965157

8

Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B; Pediatric Oncology Group Study. Chauvenet AR, et al. J Pediatr Hematol Oncol. 2003 Apr;25(4):316-20. doi: 10.1097/00043426-200304000-00010. J Pediatr Hematol Oncol. 2003. PMID: 12679647 Review.

9

Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report.

Fernández KS, Schwartz CL, Chen L, Constine LS, Chauvenet A, de Alarcón PA. Fernández KS, et al. Pediatr Blood Cancer. 2017 Dec;64(12):10.1002/pbc.26681. doi: 10.1002/pbc.26681. Epub 2017 Jun 14. Pediatr Blood Cancer. 2017. PMID: 28612375 Free PMC article.

10

APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial.

Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcon PA, Schwartz CL. Wimmer RS, et al. Among authors: chauvenet ar. Pediatr Blood Cancer. 2006 Mar;46(3):320-4. doi: 10.1002/pbc.20563. Pediatr Blood Cancer. 2006. PMID: 16200630 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters